Sepsis Diagnosis Market
This report, from Stratview Research, studies the clinical diagnostics market - sepsis diagnosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
Sepsis diagnostic has come a long way and it’s terminologies have changed many times. Currently, majority of physicians follow the qSOFA guidelines published in 2016-2017. Some of the physicians use SOFA score, or SIRS criteria for evaluation of sepsis. Inspite of that, there is variation in diagnosis resulting in high cases of morbidity and mortality, there are many factors which are responsible for this, some of the important ones are: interpretation of test results & timely intervention, too much use of antibiotics – leading to multiple drug resistance, issues of test reproducibility (specificity and sensitivity) and also the available of point of care / bedside testing and other infrastructural facilities in hospitals and clinics globally.
In 2019, it’s ironical that there is no single “gold standard” diagnostic test for sepsis, and case definitions vary widely. Use of nonspecific terminology such as “septicemia” remains pervasive. There are striking reports of sepsis among Young children, pregnant women, senior population, and patients with chronic diseases or weak immune system.
However, in developed countries which are equipped with latest facilities there are reports of less number of sepsis cases. In a study of more than 7,000 patient outcomes, using the EarlySense System, the number of ICU days for transferred patients decreased by 46 percent, the overall hospital length of stay decreased by 9 percent in the intervention group, and the number of code-blue events decreased by 86 percent, all because patients were treated as soon as they began to deteriorate. The report published by Stratview Research covers all the latest technologies which are currently being used in various market to diagnose sepsis.
The report also includes the forecast of the market, probable cases versus possible cases, import-export analysis, regulations – dos and don’t’s for the new player, growth forecast by segments such as pre-disposing factors, organisms, technology and many more. The report identifies opportunities worth more than 40 Million USD in the market between the possible cases and actual cases diagnosed.
The research showcases that not only Asia Pacific is an attractive market, Western Europe (CAGR 6.03%) appears to be more lucrative than North America (5.52% CAGR 2019-2025). While microbiology and pathology as segments would be the most attractive growing at a CAGR of 10.5% in between 2019-2025 closely followed by markers for sepsis.
This report helps the manufacturer streamline it’s marketing campaigns as the segments divide the market into site of intervention, percentage of tests conducted in hospitals versus outsourced and also looks at the granular country wise competition. The report also highlights the sepsis therapeutics as the researchers of Stratview feel that some way both are interconnected. From the KOL’s point of view the report addresses the opportunities in step wise manner – sepsis diagnosis, sepsis therapeutics and finally sepsis maintenance and recovery market, thereby covering the entire sepsis management market globally.
Apart from major markets such as USA, Germany, France, India, China and Japan, potential markets such as Indonesia, South Africa, Russia, Canada and Brazil have been studied in depth from the supplier and buyers point of view. The report gives a 360 degree overview for all the established player who would like to understand and compare a regional outlook of the sepsis diagnostic market.
For new investors and cross overs, the report provides insights on government bodies and schemes where the applicant can consider, apply and get benefited. The sepsis diagnostic report is one of a kind report which combines medical understanding for R&D team, marketing nuances and sales enhancement leads for the entire team.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global diagnostics market (sepsis diagnostics) is segmented into the following categories:
By Type of Testing
By Mode of Testing
By Site of Testing
By Type of Sepsis (Pathogen)
By Testing Facility
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.